Protocol adherence measurements | Saline (n = 123 sessions) | Albumin (n = 148 sessions) | Overall (n = 271 sessions) |
---|---|---|---|
Protocol adherence for both doses*, n (%) | 109 (89) | 135 (91) | 244 (90) |
Assigned albumin or placebo not given at start of SLED, n (%) | 4 (3) | 7 (5) | 11 (4) |
Assigned albumin or placebo not given after 4 h of SLED, n (%) | 10 (8) | 6 (4) | 16 (6) |
Both doses of assigned albumin or placebo not given, n (%) | 0 (0) | 0 (0) | 0 (0) |
Contamination measurements | |||
Received non-study intravenous albumin during the SLED session, n (%) | 19 (15)† | 13 (9)‡ | 32 (12) |